• About
  • Team
  • Contact
  • Editorial Standards
  • Core Values
  • Terms of Service
  • Privacy Policy
  • Affiliate Disclosure
Resist the Mainstream
No Result
View All Result
STORE
  • Politics
  • US
  • Media Watch
  • World
  • COVID
  • Story of Hope
  • Opinion
    • Cartoons
NEWSLETTER
Get Ad-Free Login Manage Account
  • Politics
  • US
  • Media Watch
  • World
  • COVID
  • Story of Hope
  • Opinion
    • Cartoons
No Result
View All Result
Resist the Mainstream
No Result
View All Result

FDA Reaches Agreement With Top Baby Formula Maker to Reopen Plant

RTM Staff by RTM Staff
May 16, 2022
1

RELATED

Country Music Star Zach Bryan Has a Message for Fans After Removing Woman From Concert

Elon Musk Weighs in on Why People on the Left ‘Have No Sense of Humor’

Abbott Laboratories, the baby formula producer at the center of a nationwide shortage, stated on May 16 that it reached an agreement with the U.S. Food and Drug Administration (FDA) to reopen its plant in Sturgis, Michigan, after it was subject to a federal investigation over alleged bacterial contamination.

ADVERTISEMENTS
ON
OFF

The company cautioned, however, that it could take six to eight weeks from the start of production to when formula products actually start to show up on supermarket shelves across the United States, as parents grapple with shortages.

Advertisements

The agreement between the FDA and Abbott, meanwhile, is called a consent decree, meaning it is subject to court approval, according to Abbott.

“This is a major step toward re-opening our Sturgis facility so we can ease the nationwide formula shortage,” Abbott CEO Robert Ford said in a statement. “We look forward to working with the FDA to quickly and safely re-open the facility.”

He added that “we know millions of parents and caregivers depend on us and we’re deeply sorry that our voluntary recall worsened the nationwide formula shortage” and will “work hard to re-earn the trust that moms, dads, and caregivers have placed in our formulas for more than 50 years.”

Advertisements

More than 40 percent of baby formula products are out of stock across the United States during the week ending May 8, analytics firm Datassembly stated. The supply shortage was caused, in part, by the shutdown of the Sturgis plant after four infants who allegedly consumed formula made in the facility got sick with a type of bacterial infection, including two deaths.

FDA officials said they found the presence of the bacteria Cronobacter sakazakii in the Abbott plant, although the firm last week suggested in a statement that the bacteria wasn’t linked to sick children and deaths. In February, Abbott, the largest maker of baby formula in the United States, halted production and recalled several types of formula, including the top-selling Similac brand.

Earlier on May 16, FDA Commissioner Robert Califf told the “Today” show that he doesn’t expect the baby formula shortage to last until the end of 2022, while White House press secretary Karine Jean-Pierre said the United States is working to import more baby formula products from other countries in the meantime.

This is an excerpt from The Epoch Times.

Scroll down to leave a comment and share your thoughts.

TRENDING TODAY

Trump Goes After His Former Press Secretary Kayleigh McEnany
US

Trump Goes After His Former Press Secretary Kayleigh McEnany

by RTM Staff
May 31, 2023
Cause of Death Revealed for Florida Teacher Amanda Hicks Who Was Found Dead Next to Screaming Infant
US

Cause of Death Revealed for Florida Teacher Amanda Hicks Who Was Found Dead Next to Screaming Infant

by RTM Staff
May 30, 2023


© 2023 Resist the Mainstream

Get Ad-Free Login Manage Account
No Result
View All Result
  • Newsletter
  • Store
  • Politics
  • US
  • Media Watch
  • World
  • COVID
  • Story of Hope
  • Opinion
    • Cartoons
  • About
  • Team
  • Contact
  • Editorial Standards
  • Core Values
  • Terms of Service
  • Privacy Policy
  • Affiliate Disclosure

© 2023 Resist the Mainstream

x
x